153364-63-7

Basic information

• Product Name: m-PEG4-benzaldehyde
• Synonyms: m-PEG4-benzaldehyde;mPEG4-Ph-Ald
• CAS NO: 153364-63-7
• Molecular Formula: C₁₄H₂₀O₅
• Molecular Weight: 268.3056
• Mol File: 153364-63-7.mol
• Article Data: 23

Chemical Properties

• Appearance: /
• Solubility: Soluble in DMSO, DCM, DMF
• CAS DataBase Reference: m-PEG4-benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: m-PEG4-benzaldehyde(153364-63-7)
• EPA Substance Registry System: m-PEG4-benzaldehyde(153364-63-7)

Safety Data

• Hazardous Substances Data: 153364-63-7(Hazardous Substances Data)

Usage

Description

m-PEG4-benzaldehyde is a small molecule PEG linker containing a terminal benzaldehyde moiety that can react with primary amine groups. PEG4 armr increases the solubility of compounds in aqueous media.

Uses

m-PEG4-Benzaldehyde is used in the development of biotin-decorated NIR-absorbing nanosheets for targeted photodynamic cancer therapy

Upstream product

• 72593-77-2 3,6,9-trioxadecyl bromide 
• 123-08-0 4-hydroxy-benzaldehyde 
• 62921-74-8 2-(2-(2-methoxyethoxy)ethoxy)ethyl p-toluenesulfonate 
• 139-85-5 3,4-dihydroxybenzaldehyde 
• 112-35-6 triethylene glucol monomethyl ether 
• 74654-05-0 8-methoxy-1-(methylsulfonyl)oxy-3,6-dioxaoctane 

Relevant articles and documents

Synthesis and characterization of trans-di-(4-pyridyl)porphyrin dimers

Preparation and characterization of a small library of symmetric trans-di(4-pyridyl)porphyrin dimers, obtained by either Glaser-Hay or Sonogashira coupling reactions from appropriately prepared trans-di-4-pyridylporphyrin precursors, is presented. The porphyrin dimers are differentiated by a phenyl-alkynyl bridge of increasing length at one meso-position, while for all the derivatives the two remaining opposite meso-positions are tailored with a phenyl moiety bearing a short polyether chain. Coordination of the four pyridyl groups with appropriate metal fragments may be exploited to construct tubular hollow structures, with varied internal sizes, depending on the choice of the porphyrin dimer component.

Development and characterization of nanoparticles prepared from the mixture of triterpenoids and amphiphilic meso-arylporphirins

The mixture of triterpenoids from birch bark and amphiphilic meso-arylprophyrins was used to develop spherical amorphous nanoparticles. The nanoparticles were studied with the methods of electron microscopy, dynamic light scattering, UV spectroscopy, and

Synthesis of asymmetric tetraarylporphyrins and their ytterbium complexes

The synthesis of asymmetric meso-aryl-substituted porphyrins containing three 4-methoxycarbonylphenyl groups, and 4-hydroxyphenyl or 4-hydroxy-3-methoxyphenyl radicals or isomeric 3-and 4-pyridyl radicals as a forth substitute, is described. 4-Oxyalkyl derivatives are obtained. The ytterbium complexes of these porphyrins have been synthesized, and their spectral luminescence properties have been studied. A significant difference in the lifetimes of the excited state of ytterbium complexes of the esters and acids of asymmetric porphyrins has been shown. Pleiades Publishing, Ltd., 2011.

An Ethacrynic Acid-Brominated BODIPY Photosensitizer (EA-BPS) Construct Enhances the Lethality of Reactive Oxygen Species in Hypoxic Tumor-Targeted Photodynamic Therapy

Despite being a clinically approved intervention for cancer, photodynamic therapy (PDT) still suffers from limitations. Prime among these is a therapeutic response that is mostly oxygen dependent. This limits the utility of PDT in treating hypoxic tumors

A tumor-targeted Photodynamic therapeutic compound

The present invention relates to a tumor targeting photodynamic therapeutic agent containing a compound represented by chemical formula 1. The compound according to the present invention can significantly improve cancer treatment efficiency.COPYRIGHT KIPO 2019